Regeneron Pharmaceuticals, Inc.

AE Wealth Management LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/26/2026

Shares

5,474

Value ($000)

4,226

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/26/2026	4,226	0.0%	5,474	12/31/2025
2025 Q3	11/3/2025	2,252	0.0%	4,004	9/30/2025
2025 Q2	8/6/2025	1,383	0.0%	2,633	6/30/2025
2025 Q1	5/6/2025	1,412	0.0%	2,225	3/31/2025
2024 Q4	2/13/2025	1,268	0.0%	1,780	12/31/2024
2024 Q3	11/14/2024	1,130	0.0%	1,074	9/30/2024
2024 Q2	8/12/2024	575	0.0%	547	6/30/2024
2024 Q1	5/15/2024	441	0.0%	458	3/31/2024
2023 Q4	2/14/2024	3,448	0.0%	3,668	12/31/2023
2023 Q3	10/11/2023	1,002	0.0%	1,218	9/30/2023
2023 Q2	7/10/2023	2,335	0.0%	3,249	6/30/2023
2023 Q1	4/14/2023	3,188	0.0%	3,880	3/31/2023
2022 Q4	1/31/2023	3,288	0.0%	4,557	12/31/2022
2022 Q3	10/25/2022	8,914	0.1%	12,941	9/30/2022
2022 Q2	8/3/2022	7,601	0.1%	12,859	6/30/2022
2022 Q1	4/18/2022	6,994	0.0%	10,014	3/31/2022
2021 Q4	1/20/2022	6,213	0.0%	9,838	12/31/2021
2021 Q3	11/1/2021	2,530	0.0%	4,180	9/30/2021
2021 Q2	7/21/2021	2,429	0.0%	4,349	6/30/2021
2021 Q1	4/27/2021	1,773	0.0%	3,748	3/31/2021
2020 Q4	2/1/2021	340	0.0%	704	12/31/2020
2020 Q3	11/6/2020	1,198	0.0%	2,140	9/30/2020
2020 Q2	8/5/2020	1,187	0.0%	1,904	6/30/2020
2020 Q1	5/7/2020	679	0.0%	1,390	3/31/2020
2019 Q4	1/15/2020	219	0.0%	582	12/31/2019